DE69921300D1 - Phthalimido arylpiperazinen als alpha 1a rezeptor antagonisten nützlich zur behandlung von gutartigen prostatahyperplasia - Google Patents

Phthalimido arylpiperazinen als alpha 1a rezeptor antagonisten nützlich zur behandlung von gutartigen prostatahyperplasia

Info

Publication number
DE69921300D1
DE69921300D1 DE69921300T DE69921300T DE69921300D1 DE 69921300 D1 DE69921300 D1 DE 69921300D1 DE 69921300 T DE69921300 T DE 69921300T DE 69921300 T DE69921300 T DE 69921300T DE 69921300 D1 DE69921300 D1 DE 69921300D1
Authority
DE
Germany
Prior art keywords
alpha
receptor antagonists
prostate hyperplasia
antagonists useful
arylpiperazines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69921300T
Other languages
English (en)
Other versions
DE69921300T2 (de
Inventor
Gee-Hong Kuo
V Murray
P Prouty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE69921300D1 publication Critical patent/DE69921300D1/de
Publication of DE69921300T2 publication Critical patent/DE69921300T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69921300T 1998-02-20 1999-02-19 Phthalimido arylpiperazinen als alpha 1a rezeptor antagonisten nützlich zur behandlung von gutartigen prostatahyperplasia Expired - Fee Related DE69921300T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7551098P 1998-02-20 1998-02-20
US75510P 1998-02-20
PCT/US1999/003694 WO1999042445A1 (en) 1998-02-20 1999-02-19 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia

Publications (2)

Publication Number Publication Date
DE69921300D1 true DE69921300D1 (de) 2004-11-25
DE69921300T2 DE69921300T2 (de) 2006-03-09

Family

ID=22126243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921300T Expired - Fee Related DE69921300T2 (de) 1998-02-20 1999-02-19 Phthalimido arylpiperazinen als alpha 1a rezeptor antagonisten nützlich zur behandlung von gutartigen prostatahyperplasia

Country Status (21)

Country Link
US (2) US20020077476A1 (de)
EP (1) EP1056720B1 (de)
JP (1) JP2002503722A (de)
KR (1) KR100608473B1 (de)
CN (1) CN1172911C (de)
AR (1) AR015521A1 (de)
AT (1) ATE280156T1 (de)
AU (1) AU766411B2 (de)
BR (1) BR9908122A (de)
DE (1) DE69921300T2 (de)
ES (1) ES2233023T3 (de)
HK (1) HK1031872A1 (de)
HU (1) HUP0100704A3 (de)
IL (2) IL137953A0 (de)
NO (1) NO317104B1 (de)
NZ (1) NZ506461A (de)
PL (1) PL194649B1 (de)
PT (1) PT1056720E (de)
TR (1) TR200003224T2 (de)
WO (1) WO1999042445A1 (de)
ZA (1) ZA991319B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010164A1 (it) * 2001-01-30 2002-07-30 Recordati Chem Pharm Alfa 1 antagonisti selettivi a + d
CN103387531A (zh) * 2012-05-10 2013-11-13 广州医学院 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性前列腺增生中的应用
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN106966940B (zh) * 2015-07-30 2019-03-19 新发药业有限公司 一种西他列汀磷酸盐中间体n-芳甲基-2s-氰基甲基吖啶的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1382742A (en) 1972-09-19 1975-02-05 Labaz Benzofuran derivatives and process for preparing the same
CH585693A5 (de) 1974-02-08 1977-03-15 Ciba Geigy Ag
HU177702B (en) 1977-10-24 1981-12-28 Noevenyvedelmi Kutato Intezet Plant growth regulator and process for preparing the active materials
PT82077B (fr) * 1985-02-26 1987-09-25 Sanofi Sa Procede pour l'obtention des derives aminoalcools peptidiques inhibiteurs de la renine et des proteases acides
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases
CN1515556A (zh) * 1997-05-12 2004-07-28 ����-������ҩƷ��˾ 用以制备芳基取代哌嗪的中间体化合物

Also Published As

Publication number Publication date
IL137953A0 (en) 2001-10-31
PL342357A1 (en) 2001-06-04
US20020077476A1 (en) 2002-06-20
JP2002503722A (ja) 2002-02-05
AU2776599A (en) 1999-09-06
CN1291185A (zh) 2001-04-11
DE69921300T2 (de) 2006-03-09
BR9908122A (pt) 2001-11-13
HUP0100704A3 (en) 2002-10-28
ATE280156T1 (de) 2004-11-15
HK1031872A1 (en) 2001-06-29
AU766411B2 (en) 2003-10-16
NO20004142L (no) 2000-10-19
KR20010041118A (ko) 2001-05-15
AR015521A1 (es) 2001-05-02
NO317104B1 (no) 2004-08-09
EP1056720B1 (de) 2004-10-20
TR200003224T2 (tr) 2001-03-21
KR100608473B1 (ko) 2006-08-09
ES2233023T3 (es) 2005-06-01
NO20004142D0 (no) 2000-08-18
WO1999042445A1 (en) 1999-08-26
US6780994B2 (en) 2004-08-24
ZA991319B (en) 2000-11-20
PL194649B1 (pl) 2007-06-29
HUP0100704A2 (hu) 2001-10-28
NZ506461A (en) 2003-08-29
CN1172911C (zh) 2004-10-27
PT1056720E (pt) 2005-02-28
EP1056720A1 (de) 2000-12-06
IL137953A (en) 2006-12-31
US20030088099A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
DE60017179D1 (de) Tyrosin kinaseinhibitoren
MA26762A1 (fr) Derives de pyrrolidine- antagonistes du recepteur ccr-3
ATE263151T1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
DE69809726D1 (de) Substituierte analoge von indol-3-carbinol und von diindolmethan als antiestrogene
DE69815313D1 (de) Chinolin- und chinazolin-verbindungen von therapeutischem nutzen, insbesondere zur behandlung von gutartiger prostatahyperplasie
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
ATE357443T1 (de) Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten
DE60032905D1 (de) Selektive iglur5 rezeptorantagonisten zur behandlung der migräne
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE69903961T2 (de) Muscarinagonisten und antagonisten
DE60009888D1 (de) Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
ATE381938T1 (de) Verwendungen zur behandlung von fsh-verbundenen zuständen mit gnrh antagonisten
DE69715886D1 (de) Acylaminoalkenylen-amid-derivate als nk1 und nk2 antagonisten
DE69721756T2 (de) Paroxetine zur behandlung von depression
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69921300D1 (de) Phthalimido arylpiperazinen als alpha 1a rezeptor antagonisten nützlich zur behandlung von gutartigen prostatahyperplasia
ATE250580T1 (de) Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
DE69904849D1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
DE69918541D1 (de) Verwendung von nmda antagonisten zur behandlung des reizkolons
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69928501D1 (de) Mittel zur vorbeugung/behandlung von osteoporose
DE69812599D1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee